Literature DB >> 725519

The role of serum ferritin in the management of idiopathic haemochromatosis.

R G Batey, S Hussein, S Sherlock, A V Hoffbrand.   

Abstract

The value of the serum ferritin assay in the management of idiopathic haemochromatosis has been examined in groups of patients at diagnosis, during venesection therapy, and following completion of therapy. At diagnosis, serum ferritin levels were elevated in all 16 patients studied, including 10 with precirrhotic disease. Venesection resulted in a gradual fall in serum ferritin which commenced shortly after the start of treatment in 5/8 patients. In 3/8 the fall was preceded by a transient rise in ferritin levels. In three patients serum ferritin fell to normal before liver iron stores had been restored to normal. After therapy serum ferritin proved unreliable in detecting early re-accumulation of hepatic iron stores. Serum ferritin does provide valuable information in patients with idiopathic haemochromatosis, particularly at diagnosis and during therapy. A normal value does not exclude iron storage disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 725519     DOI: 10.3109/00365527809181375

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Computed tomography for determining liver iron content in primary haemochromatosis.

Authors:  R W Chapman; G Williams; G Bydder; R Dick; S Sherlock; L Kreel
Journal:  Br Med J       Date:  1980-02-16

2.  Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta-thalassaemia major and iron overload.

Authors:  R W Chapman; M A Hussain; A Gorman; M Laulicht; D Politis; D M Flynn; S Sherlock; A V Hoffbrand
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

Review 3.  Plasma ferritin concentrations: their clinical significance and relevance to patient care.

Authors:  L S Valberg
Journal:  Can Med Assoc J       Date:  1980-06-07       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.